Regenerative medicine of bone and cartilage

Shinsuke Ohba, Kazuyo Igawa, Kozo Nakamura, Hiroshi Kawaguchi, Tsuyoshi Takato, Ung il Chung

Research output: Contribution to journalReview article

Abstract

Regenerative medicine, which takes advantage of the unique capacity of stem cells, is a novel medical strategy to cure irreversible organ failure. There are three important elements in regenerative medicine: cells, scaffolds and signals. Although substantial progress regarding each element has been made in the past few years, it still falls short of clinical applications. In the geriatric field, osteoporosis, osteoarthritis and periodontitis are the major targets of regenerative medicine. They are usually not life-threatening, but often severely affect QOL of elderly patients. Since elderly people have already reduced number of stem cells in bone and cartilage, we need to know the sufficient conditions for osteogenesis and chondrogenesis by comprehensively screening various conditions. We developed a marker gene system expressing green fluorescence protein (GFP) under the control of osteoblast- and chondrocyte-specific promoters. This system helps us monitor osteoblast and chondrocyte differentiation easily, precisely and non-invasively. Using this system, we are now trying to find the sufficient conditions for osteogenesis and chondrogenesis, and to discover osteogenic and chondrogenic small compounds.

Original languageEnglish
Pages (from-to)582-588
Number of pages7
JournalNippon Ronen Igakkai zasshi. Japanese journal of geriatrics
Volume41
Issue number6
Publication statusPublished - Nov 2004
Externally publishedYes

Fingerprint

Regenerative Medicine
Cartilage
Chondrogenesis
Chondrocytes
Osteoblasts
Osteogenesis
Bone and Bones
Stem Cells
Periodontitis
Osteoarthritis
Geriatrics
Osteoporosis
Fluorescence
Genes
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ohba, S., Igawa, K., Nakamura, K., Kawaguchi, H., Takato, T., & Chung, U. I. (2004). Regenerative medicine of bone and cartilage. Nippon Ronen Igakkai zasshi. Japanese journal of geriatrics, 41(6), 582-588.

Regenerative medicine of bone and cartilage. / Ohba, Shinsuke; Igawa, Kazuyo; Nakamura, Kozo; Kawaguchi, Hiroshi; Takato, Tsuyoshi; Chung, Ung il.

In: Nippon Ronen Igakkai zasshi. Japanese journal of geriatrics, Vol. 41, No. 6, 11.2004, p. 582-588.

Research output: Contribution to journalReview article

Ohba, S, Igawa, K, Nakamura, K, Kawaguchi, H, Takato, T & Chung, UI 2004, 'Regenerative medicine of bone and cartilage', Nippon Ronen Igakkai zasshi. Japanese journal of geriatrics, vol. 41, no. 6, pp. 582-588.
Ohba S, Igawa K, Nakamura K, Kawaguchi H, Takato T, Chung UI. Regenerative medicine of bone and cartilage. Nippon Ronen Igakkai zasshi. Japanese journal of geriatrics. 2004 Nov;41(6):582-588.
Ohba, Shinsuke ; Igawa, Kazuyo ; Nakamura, Kozo ; Kawaguchi, Hiroshi ; Takato, Tsuyoshi ; Chung, Ung il. / Regenerative medicine of bone and cartilage. In: Nippon Ronen Igakkai zasshi. Japanese journal of geriatrics. 2004 ; Vol. 41, No. 6. pp. 582-588.
@article{f4389023ff584d1e89735c580d9c86c8,
title = "Regenerative medicine of bone and cartilage",
abstract = "Regenerative medicine, which takes advantage of the unique capacity of stem cells, is a novel medical strategy to cure irreversible organ failure. There are three important elements in regenerative medicine: cells, scaffolds and signals. Although substantial progress regarding each element has been made in the past few years, it still falls short of clinical applications. In the geriatric field, osteoporosis, osteoarthritis and periodontitis are the major targets of regenerative medicine. They are usually not life-threatening, but often severely affect QOL of elderly patients. Since elderly people have already reduced number of stem cells in bone and cartilage, we need to know the sufficient conditions for osteogenesis and chondrogenesis by comprehensively screening various conditions. We developed a marker gene system expressing green fluorescence protein (GFP) under the control of osteoblast- and chondrocyte-specific promoters. This system helps us monitor osteoblast and chondrocyte differentiation easily, precisely and non-invasively. Using this system, we are now trying to find the sufficient conditions for osteogenesis and chondrogenesis, and to discover osteogenic and chondrogenic small compounds.",
author = "Shinsuke Ohba and Kazuyo Igawa and Kozo Nakamura and Hiroshi Kawaguchi and Tsuyoshi Takato and Chung, {Ung il}",
year = "2004",
month = "11",
language = "English",
volume = "41",
pages = "582--588",
journal = "Japanese Journal of Geriatrics",
issn = "0300-9173",
publisher = "Japan Geriatrics Society",
number = "6",

}

TY - JOUR

T1 - Regenerative medicine of bone and cartilage

AU - Ohba, Shinsuke

AU - Igawa, Kazuyo

AU - Nakamura, Kozo

AU - Kawaguchi, Hiroshi

AU - Takato, Tsuyoshi

AU - Chung, Ung il

PY - 2004/11

Y1 - 2004/11

N2 - Regenerative medicine, which takes advantage of the unique capacity of stem cells, is a novel medical strategy to cure irreversible organ failure. There are three important elements in regenerative medicine: cells, scaffolds and signals. Although substantial progress regarding each element has been made in the past few years, it still falls short of clinical applications. In the geriatric field, osteoporosis, osteoarthritis and periodontitis are the major targets of regenerative medicine. They are usually not life-threatening, but often severely affect QOL of elderly patients. Since elderly people have already reduced number of stem cells in bone and cartilage, we need to know the sufficient conditions for osteogenesis and chondrogenesis by comprehensively screening various conditions. We developed a marker gene system expressing green fluorescence protein (GFP) under the control of osteoblast- and chondrocyte-specific promoters. This system helps us monitor osteoblast and chondrocyte differentiation easily, precisely and non-invasively. Using this system, we are now trying to find the sufficient conditions for osteogenesis and chondrogenesis, and to discover osteogenic and chondrogenic small compounds.

AB - Regenerative medicine, which takes advantage of the unique capacity of stem cells, is a novel medical strategy to cure irreversible organ failure. There are three important elements in regenerative medicine: cells, scaffolds and signals. Although substantial progress regarding each element has been made in the past few years, it still falls short of clinical applications. In the geriatric field, osteoporosis, osteoarthritis and periodontitis are the major targets of regenerative medicine. They are usually not life-threatening, but often severely affect QOL of elderly patients. Since elderly people have already reduced number of stem cells in bone and cartilage, we need to know the sufficient conditions for osteogenesis and chondrogenesis by comprehensively screening various conditions. We developed a marker gene system expressing green fluorescence protein (GFP) under the control of osteoblast- and chondrocyte-specific promoters. This system helps us monitor osteoblast and chondrocyte differentiation easily, precisely and non-invasively. Using this system, we are now trying to find the sufficient conditions for osteogenesis and chondrogenesis, and to discover osteogenic and chondrogenic small compounds.

UR - http://www.scopus.com/inward/record.url?scp=13744259084&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13744259084&partnerID=8YFLogxK

M3 - Review article

C2 - 15651365

AN - SCOPUS:13744259084

VL - 41

SP - 582

EP - 588

JO - Japanese Journal of Geriatrics

JF - Japanese Journal of Geriatrics

SN - 0300-9173

IS - 6

ER -